immunology advancement - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Booz Allen Hamilton (NYSE: BAH) jumps 10% as defense backlog strengthens

Sila raises $300m as Moses Lake anode plant tests U.S. battery sovereignty

Representative image. An open-pit copper mining operation highlights the strategic importance of copper assets as Glencore plc’s 2025 results underline a shift toward copper-led growth and long-term capital discipline.

Evolution Mining agrees A$213m Carnaby Resources deal to expand Ernest Henry copper growth

Catalyst Metals (ASX: CYL) jumps 10% as Plutonic gold growth case returns to focus

AbbVie wraps up strategic acquisition of Landos Biopharma for $137.5 million to enhance its immunology portfolio and promises advancements in IBD treatment.

Read More

Pharma Industry News

AbbVie completes acquisition of Landos Biopharma to strengthen immunology portfolio

AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has announced the completion of its acquisition of Landos Biopharma,…

byPallavi Madhiraju

May 25, 2024

web analytics